SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-036150
Filing Date
2020-08-04
Accepted
2020-08-04 16:38:54
Documents
14
Period of Report
2020-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K myok-8k_20200804.htm   iXBRL 8-K 41346
2 EX-99.1 myok-ex991_69.htm EX-99.1 252616
3 GRAPHIC gcuxshgowenx000001.jpg GRAPHIC 17233
  Complete submission text file 0001564590-20-036150.txt   459526

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA myok-20200804.xsd EX-101.SCH 5780
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20200804_lab.xml EX-101.LAB 18708
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20200804_pre.xml EX-101.PRE 11176
7 EXTRACTED XBRL INSTANCE DOCUMENT myok-8k_20200804_htm.xml XML 3417
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 201073848
SIC: 2834 Pharmaceutical Preparations